European Immunization Week 2018- Statement of Guido Rasi, Executive Director, European Medicines Agency

Posted on: 26/04/2018 - 13:27

Vaccines matter for each of us: yearly, they prevent 2.7 million people from contracting measles, one million from getting whooping cough and two million babies from getting tetanus. They eradicated smallpox. They stopped polio, a dreadful disease affecting millions of children, in almost all... more

Field of Interest: European Union Medical News
Type: News Feed

11th EFIM Day

Submitted by Catalina on 7 May 2026 - 15:16

Save the Date - 11th EFIM Day 

Mark your calendars for the 11th EFIM Day, taking place in Brussels on Friday, October 16th, 2026.

EJCRIM is seeking an Assistant Editor

Submitted by Aneta on 7 May 2026 - 14:10

The European Journal of Case Reports in Internal Medicine (EJCRIM) - official journal of EFIM entirely dedicated to case reports - is seeking an Assistant Editor to join its editorial team and to be part of the Editorial Board of the journal.
This role is an opportunity for an experienced internal medicine physician to help to shape the dissemination of high-quality clinical case reports.
Please note that this is a voluntary position and does not include any financial compensation honorarium.

Key Responsibilities:

Human medicines European public assessment report (EPAR): Kerendia, finerenone, Date of authorisation: 16/02/2022, Revision: 4, Status: Authorised

Submitted by Anonymous (not verified) on 7 May 2026 - 10:47

Human medicines European public assessment report (EPAR): Kerendia, finerenone, Date of authorisation: 16/02/2022, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR): Dovprela (previously Pretomanid FGK), pretomanid, Date of authorisation: 31/07/2020, Revision: 14, Status: Authorised

Submitted by Anonymous (not verified) on 7 May 2026 - 10:10

Human medicines European public assessment report (EPAR): Dovprela (previously Pretomanid FGK), pretomanid, Date of authorisation: 31/07/2020, Revision: 14, Status: Authorised

Human medicines European public assessment report (EPAR): Oncaspar, pegaspargase, Date of authorisation: 14/01/2016, Revision: 20, Status: Authorised

Submitted by Anonymous (not verified) on 7 May 2026 - 9:54

Human medicines European public assessment report (EPAR): Oncaspar, pegaspargase, Date of authorisation: 14/01/2016, Revision: 20, Status: Authorised

Clinical Trials Information System (CTIS): Information day, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 17 June 2026, 12:30 (CEST) to 17 June 2026, 17:30 (CEST)

Submitted by Anonymous (not verified) on 7 May 2026 - 9:15

Clinical Trials Information System (CTIS): Information day, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 17 June 2026, 12:30 (CEST) to 17 June 2026, 17:30 (CEST)

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness